Annexon Bio News and Activities

Annexon Bio is one of the...

• Russell 3000;
• TOB Iconic 10,000.

Annexon Bio is a company listed under the stock ticker ANNX (US).

View the org chart displaying its 23 main executives

Most searched biographies at Annexon Bio

• Douglas Love, Director, President and Chief Executive Officer
• William Carson, Director
• Muneer Satter, Director

Popular executive movements at Annexon Bio

• Samarth Virk, Senior Director, Digital Marketing, has left the company  (posted on April 15 2026).

Create your alert
to follow the executive moves at Annexon Bio.

Annexon Bio has 2,425 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• Chemomab and Scipher Medicine have announced they will merge  (posted on July 13 2026)..
• Chemomab and Scipher Medicine have announced they will merge  (posted on July 13 2026)..
• Apnimed has filed its IPO. Its stock ticker will be APMD. (posted on July 13 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Robert Gould - Board Member at Fulcrum Therapeutics

Learn more about the Biotechnology industry

Press releases by Annexon Bio

• Annexon Biosciences Reports Second Quarter 2020 Financial Results and Recent Highlights | Annexon Inc.
• Annexon Biosciences Expands Leadership Team with the Appointment of Michael Overdorf as Chief Business Officer | Annexon Inc.
• Annexon Announces Closing of Initial Public Offering | Annexon Inc.
• Annexon Closes $100 Million Financing to Advance Broad Pipeline of Classical Complement Therapeutics | Annexon Inc.
• Annexon Announces Pricing of Initial Public Offering | Annexon Inc.
• News Releases | Annexon Inc.
• View more press releases Close

Social media about Annexon Bio

• Annexon Bio on Wikipedia, Google News & Yahoo Finance
• Annexon Bio on LinkedIn, X (Twitter) & YouTube